Literature DB >> 7093926

The effects of radiation therapy for Hodgkin's disease in a child with ataxia telangiectasia: a clinical, biological and pathologic study.

J Pritchard, M R Sandland, F B Breatnach, J R Pincott, R Cox, P Husband.   

Abstract

Stage I lymphocyte-predominant Hodgkin's disease was diagnosed in a 44-month-old girl. Although immune deficiency was suspected and IgA deficiency demonstrated, the diagnosis of an ataxia-telangiectasia (AT)-like syndrome was not confirmed until eight weeks later when results of studies on the radiosensitivity of cultured skin fibroblasts were available. The child had none of the usual physical stigmata of AT. Severe acute radiation damage followed the treatment of this child with standard doses of radiation therapy. Clinical, pathologic, and radiobiologic correlations are drawn. The diagnosis of a malignant lymphoma disorder in children under the age of five should alert clinicians to the possibility of immune deficiency and, even in the absence of classical physical signs, to AT in particular. Suggestions for the management of future similar cases are put forward.

Entities:  

Mesh:

Year:  1982        PMID: 7093926     DOI: 10.1002/1097-0142(19820901)50:5<877::aid-cncr2820500513>3.0.co;2-u

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  10 in total

Review 1.  [Genetic predisposition and radiation sensitivity of tumors].

Authors:  W Budach
Journal:  Strahlenther Onkol       Date:  1997-09       Impact factor: 3.621

Review 2.  Clinical radiation sensitivity with DNA repair disorders: an overview.

Authors:  Julianne M Pollard; Richard A Gatti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-08-01       Impact factor: 7.038

3.  Leukoencephalopathy after prophylactic radiation for leukaemia in ataxia telangiectasia.

Authors:  J Pritchard
Journal:  Arch Dis Child       Date:  1989-05       Impact factor: 3.791

4.  Selective IgA deficiency in children in Israel.

Authors:  Vered Shkalim; Yehudit Monselize; Nirit Segal; Israel Zan-Bar; Vered Hoffer; Ben Zion Garty
Journal:  J Clin Immunol       Date:  2010-06-23       Impact factor: 8.317

5.  Central Nervous System Distribution of the Ataxia-Telangiectasia Mutated Kinase Inhibitor AZD1390: Implications for the Treatment of Brain Tumors.

Authors:  Surabhi Talele; Wenjuan Zhang; Jiajia Chen; Shiv K Gupta; Danielle M Burgenske; Jann N Sarkaria; William F Elmquist
Journal:  J Pharmacol Exp Ther       Date:  2022-08-05       Impact factor: 4.402

6.  Cranial MRI in ataxia-telangiectasia.

Authors:  F Sardanelli; R C Parodi; C Ottonello; P Renzetti; S Saitta; E Lignana; G L Mancardi
Journal:  Neuroradiology       Date:  1995-01       Impact factor: 2.804

7.  Leukoencephalopathy after prophylactic radiation for leukaemia in ataxia telangiectasia.

Authors:  J A Eyre; D Gardner-Medwin; G P Summerfield
Journal:  Arch Dis Child       Date:  1988-09       Impact factor: 3.791

Review 8.  Ataxia telangiectasia genes and predisposition to leukaemia, lymphoma and breast cancer.

Authors:  A M Taylor
Journal:  Br J Cancer       Date:  1992-07       Impact factor: 7.640

9.  The natural history of ataxia-telangiectasia (A-T): A systematic review.

Authors:  Emily Petley; Alexander Yule; Shaun Alexander; Shalini Ojha; William P Whitehouse
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.752

Review 10.  What Does the History of Research on the Repair of DNA Double-Strand Breaks Tell Us?-A Comprehensive Review of Human Radiosensitivity.

Authors:  Elise Berthel; Mélanie L Ferlazzo; Clément Devic; Michel Bourguignon; Nicolas Foray
Journal:  Int J Mol Sci       Date:  2019-10-26       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.